Search

Your search keyword '"Pedersen T"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Pedersen T" Remove constraint Author: "Pedersen T" Topic anticholesteremic agents Remove constraint Topic: anticholesteremic agents
31 results on '"Pedersen T"'

Search Results

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

2. A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.

3. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

4. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.

5. Statins--similarities and differences.

6. Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data.

7. Pro and con: low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management.

8. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.

9. Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study.

10. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

11. Statin trials and goals of cholesterol-lowering therapy after AMI.

12. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.

13. Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S)

14. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

15. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

16. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease.

17. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

18. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

19. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.

20. Review of cholesterol-lowering therapy: coronary angiographic and events trials.

21. Lipid-lowering therapy for patients with or at risk of coronary artery disease.

22. Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)

23. Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.

24. Trials of lipid-lowering therapy in secondary prevention of coronary heart disease.

25. Lowering cholesterol with drugs and diet.

26. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).

27. [Unfortunate report on simvastatin therapy in the mass media].

28. Evolocumab and clinical outcomes in patients with cardiovascular disease

29. Ezetimibe added to statin therapy after acute coronary syndromes

30. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

31. The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice

Catalog

Books, media, physical & digital resources